Ephedrine Sulfate Injection, USP, 50 mg/mL, 1mL Single Dose Ampules, For Intrave Supply Disruption — Akorn, Inc. (Moderate Risk —
Ephedrine Sulfate Injection, USP, 50 mg/mL, 1mL Single Dose Ampules, For Intrave Supply Disruption — Akorn, Inc. (Moderate Risk — is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Ephedrine Sulfate Injection, USP, 50 mg/mL, 1mL Single Dose Ampules, For Intrave; Manufacturer: Akorn,
| Drug name | Ephedrine Sulfate Injection, USP, 50 mg/mL, 1mL Single Dose Ampules, For Intrave |
|---|---|
| Manufacturer | Akorn, Inc. |
| Recall/Disruption reason | CGMP Deviations: Firm went out of business and could no longer continue stability studies. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-0802-2023 |
| Initiation date | 20230426 |
| Quantity affected | N/A |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →